Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (58)

2024

  1. Applicability of the Zwolle score for selection of very high-risk ST-elevation myocardial infarction patients treated with primary angioplasty

    Angiology, Vol. 75, Núm. 2, pp. 175-181

2023

  1. Differential prognosis of patients that are candidates for standard, short or prolonged dual antiplatelet treatment discharged after an acute coronary syndrome

    Thrombosis Research, Vol. 224, pp. 46-51

  2. Remnant cholesterol in patients admitted for acute coronary syndromes

    European journal of preventive cardiology, Vol. 30, Núm. 4, pp. 340-348

  3. The efficacy of intensive lipid-lowering therapies on the reduction of LDLc and of major cardiovascular events

    Journal of Clinical Lipidology, Vol. 17, Núm. 5, pp. 602-611

2022

  1. Clinical and therapeutic characterization of the ischemic cardiopathy in Spain. Importance of cardiac rehabilitation programs

    Medicina Clinica Practica, Vol. 5, Núm. 3

  2. Early angiography in elderly patients with non-ST-segment elevation acute coronary syndrome: The cardio CHUS-HUSJ registry

    International Journal of Cardiology, Vol. 351, pp. 8-14

  3. Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 5, pp. 245-252

  4. Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril-Valsartan in Clinical Trials

    American journal of therapeutics, Vol. 29, Núm. 5, pp. e572-e575

  5. Should PRECISE-DAPT be included for long-term prognostic stratification of diabetic patients with NSTEACS?

    Acta Diabetologica, Vol. 59, Núm. 2, pp. 163-170

  6. The CNIC-Polypill reduces recurrent major cardiovascular events in real-life secondary prevention patients in Spain: The NEPTUNO study

    International Journal of Cardiology, Vol. 361, pp. 116-123

2021

  1. Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome

    Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 765-772

  2. Direct Oral Anticoagulants Versus Vitamin-K Antagonist After PCIs in Patients With AF: A Meta-analysis of Cardiac Ischemic Events

    Journal of cardiovascular pharmacology, Vol. 77, Núm. 2, pp. 164-169

  3. Impact of comorbidities in the decision of using invasive management in elderly patients with NSTEACS

    REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 15-20

  4. Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48

  5. Long term prognostic benefit of complete revascularization in elderly presenting with NSTEMI: Real world evidence

    Reviews in Cardiovascular Medicine, Vol. 22, Núm. 2, pp. 475-482

  6. Managing NSTEMI in older patients

    The Lancet

  7. Mortality associated with cardiovascular disease in patients with COVID-19

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 30-38

  8. Multicenter and all-comers validation of a score to select patients for manual thrombectomy, the DDTA score

    Catheterization and Cardiovascular Interventions, Vol. 98, Núm. 3, pp. E342-E350

  9. New-onset heart failure after acute coronary syndrome in patients without heart failure or left ventricular dysfunction

    Revista Espanola de Cardiologia, Vol. 74, Núm. 6, pp. 494-501

  10. Prognosis impact of diabetes in elderly women and men with non-st elevation acute coronary syndrome

    Journal of Clinical Medicine, Vol. 10, Núm. 19